The END RHD CRE: Developing an endgame for rheumatic heart disease in Australia [ 2014 - ]

Research Grant

Researchers: Prof Jonathan Carapetis (Principal investigator) ,  A/Pr Anna Ralph ,  A/Pr Daniel McAullay ,  Ms Heather D'Antoine ,  Prof Alex Brown
View all 11 related researchers

Brief description Rheumatic heart disease (RHD) is caused by an abnormal immune reaction to some bacterial infections. Although RHD is rare in developed countries, Indigenous Australians still live with the burden of RHD. The END RHD CRE will explore risk factors for RHD, prevention with antibiotics, management of RHD and the potential for vaccine development. Individuals and communities experiencing RHD are integral partners to this work. The CRE will establish a strategy for ending RHD in Australia.

Funding Amount $2,496,816.00

Funding Scheme Centres of Research Excellence

Notes Centre of Research Excellence - Population Health